PROSTATE CANCER

Fox Chase Cancer Center
With a U.S. News & World Report ranking of 11th in the country for cancer, the 100-bed center treats nothing but cancer and prides itself on offering patients technology-driven treatment delivered by quality physicians in their chosen sub-specialties. Its investigators have won some of the leading awards in medicine, including the Nobel and Lasker prizes. Fox Chase is a leader in risk-assessment programs for melanoma, GI and prostate cancers, and for women with family histories of breast and ovarian cancer (333 Cottman Avenue, 888-FOX CHASE).

Abramson Cancer Center
UPHS’s big-umbrella, with its number 29 slot in U.S. News, has a strong Urologic Cancer Program, which has created a device that provides one of the most precise images of the prostate gland possible in order to facilitate more accurate staging of prostate tumors. Moreover, at any given time, 200 clinical trials are available to patients at the center, supported by a whopping $200 million in federal grants (3400 Spruce Street, 800-789-PENN).

Kimmel Cancer Center at Jefferson Hospital
The 150 physicians and scientists at the Kimmel Cancer Center are discovering and developing novel approaches to cancer treatment while trying to better understand the way the disease behaves. Toward this end, they conduct more than 100 clinical trials a year and manage 20 institutions in the area in the cancer-care business. They bridge mainstream medicine with alternative and complementary therapies through the hospital’s integrative medicine program and the busy radiation oncology center offers all the latest modalities. Kimmel’s Multidisciplinary Genitourinary Center provides those with urological cancers input from multiple cancer specialists in order to determine an appropriate treatment plan, and in one of their current clinical trials, they are testing the prospective of selenium for prostate cancer prevention (233 South 10th Street, 800-JEFF-NOW).